Search for: "Cephalon Inc. et al v. Mylan Pharmaceuticals Inc. et al" Results 1 - 20 of 25
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Nov 2011, 9:40 pm by Patent Docs
Cephalon Inc. et al. v. [read post]
4 Mar 2012, 8:24 pm by Patent Docs
Mylan Pharmaceuticals Inc. et al. 1:12-cv-00247; filed February 29, 2012 in the District Court of Delaware • Plaintiff: Cephalon Inc. [read post]
29 Jan 2012, 8:59 pm by Patent Docs
Mylan Pharmaceuticals Inc. et al. 1:12-cv-00073; filed January 24, 2012 in the District Court of Delaware • Plaintiff: Cephalon Inc. [read post]
1 Dec 2008, 3:33 am
Mylan Pharmaceuticals, Inc. et al.1:08-cv-00210; filed November 26, 2008 in the Northern District of West VirginiaEurand, Inc. et al. v. [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
12/2: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Novartis Corporation, et al. v. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Ltd., Nintendo of America Inc., Sony Corporation, Sony Computer Entertainment Inc., Sony Computer Entertainment America, Inc., et al. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) (Patent Quality Review Blog) Nuvigil (Armodafinil) – US: Patent infringement complaint filed following a Para IV certification: Cephalon, Inc. et al. v. [read post]
24 Nov 2010, 12:37 am by Kelly
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb)   General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
9 Mar 2011, 3:00 am by Marie Louise
Bayer AG  (FDA Law Blog) (Patent Docs) Dexilant (Dexlansoprazole) – US: Takeda files patent infringement suit against Handa following Para IV certification filing (Patent Docs) EpiPen – US: Orange Book patent delisting counterclaim raised in 505(b)(2) application patent infringement litigation; decision could provide guidance on drug delivery system patent listability: King Pharmaceuticals v Intelliject (FDA Law Blog) Fentora (Fentanyl) – US:… [read post]